Speech Therapy for Speech Sound Disorder
(iChain Trial)
Trial Summary
What is the purpose of this trial?
This trial is testing two different schedules for speech therapy in children with persistent speech problems. One schedule spreads sessions over a longer period, while the other packs them into a shorter time. The idea is that more frequent sessions might help children learn correct speech sounds better by reducing mistakes between sessions.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Intensive Speech Motor Chaining Treatment for Speech Sound Disorder?
Research shows that Speech Motor Chaining (SMC) can help children with speech sound disorders successfully learn new speech patterns and apply them to words they haven't practiced. Clinicians can implement this method effectively, and children can achieve a high number of practice trials per session, leading to improved speech outcomes.12345
Is Speech Motor Chaining Treatment safe for children with speech sound disorders?
How is the Intensive Speech Motor Chaining Treatment different from other treatments for speech sound disorders?
The Intensive Speech Motor Chaining Treatment is unique because it focuses on building complex speech patterns around core movements using principles of motor learning, such as feedback manipulation and practice variability, which helps children generalize learned speech patterns to new words.1491011
Research Team
Jonathan Preston, PhD
Principal Investigator
Syracuse University
Eligibility Criteria
This trial is for American English-speaking children aged 9 to 17 with speech sound disorders, specifically difficulty with /ɹ/ and /s/ sounds. They must have started learning English by age 3, pass a hearing test, score adequately on language understanding tests, and want to improve their speech. Children with cleft palate, voice disorders, autism spectrum disorder, Down Syndrome, cerebral palsy, intellectual disability or brain injury are excluded.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive Speech Motor Chaining treatment. Distributed schedule: 2 sessions per week for 8 weeks. Intensive schedule: 16 sessions over 4 weeks.
Follow-up
Participants are monitored for speech sound learning and social, emotional, and academic impacts after treatment
Treatment Details
Interventions
- Intensive Speech Motor Chaining Treatment (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Syracuse University
Lead Sponsor
State University of New York - Upstate Medical University
Collaborator
Dr. Amy Tucker
State University of New York - Upstate Medical University
Chief Medical Officer
MD, MHCM
Dr. Robert J. Corona
State University of New York - Upstate Medical University
Chief Executive Officer since 2019
DO from New York Institute of Technology College of Osteopathic Medicine, MBA from University of Massachusetts at Amherst
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator
Joshua M. Levy
National Institute on Deafness and Other Communication Disorders (NIDCD)
Chief Medical Officer
MD, MPH, MS
Debara L. Tucci
National Institute on Deafness and Other Communication Disorders (NIDCD)
Chief Executive Officer since 2019
MD, MS, MBA
National Institutes of Health (NIH)
Collaborator
Dr. Jeanne Marrazzo
National Institutes of Health (NIH)
Chief Medical Officer
MD from University of California, Los Angeles
Dr. Jay Bhattacharya
National Institutes of Health (NIH)
Chief Executive Officer
MD, PhD from Stanford University